{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:36:14Z","timestamp":1791909374946,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071967"],"award-info":[{"award-number":["82071967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Key Research and Development Program of China","award":["2020YFC2002702"],"award-info":[{"award-number":["2020YFC2002702"]}]},{"DOI":"10.13039\/501100019018","name":"CAMS Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["CAMS-2018-I2M-3-001"],"award-info":[{"award-number":["CAMS-2018-I2M-3-001"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019018","name":"CAMS initiative for innovative medicine","doi-asserted-by":"crossref","award":["2016ZX310174-4"],"award-info":[{"award-number":["2016ZX310174-4"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program","award":["52300300519"],"award-info":[{"award-number":["52300300519"]}]},{"name":"Capital 's Funds for Health Improvement and Research","award":["CFH-2018-2-4014"],"award-info":[{"award-number":["CFH-2018-2-4014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00259-023-06297-y","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T03:01:34Z","timestamp":1690340494000},"page":"4036-4050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparing the clinical value of baseline [68\u00a0Ga]Ga-FAPI-04 PET\/CT and [18F]F-FDG PET\/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis"],"prefix":"10.1007","volume":"50","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-083X","authenticated-orcid":false,"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"10242","key":"6297_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30974-0.","journal-title":"Lancet"},{"issue":"1","key":"6297_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.surg.2013.06.050","volume":"155","author":"M Miyazaki","year":"2014","unstructured":"Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, et al. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile? Surgery. 2014;155(1):58\u201366. https:\/\/doi.org\/10.1016\/j.surg.2013.06.050.","journal-title":"Surgery"},{"key":"6297_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/tgh.2019.04.09","volume":"4","author":"F Scheufele","year":"2019","unstructured":"Scheufele F, Hartmann D, Friess H. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable\/locally advanced pancreatic cancer. Transl Gastroenterol Hepatol. 2019;4:32. https:\/\/doi.org\/10.21037\/tgh.2019.04.09.","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"7","key":"6297_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejso.2014.03.016","volume":"40","author":"AP Rijkers","year":"2014","unstructured":"Rijkers AP, Valkema R, Duivenvoorden HJ, van Eijck CH. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis. Eur J Surg Oncol. 2014;40(7):794\u2013804. https:\/\/doi.org\/10.1016\/j.ejso.2014.03.016.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"6297_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","volume":"9","author":"M Erkan","year":"2012","unstructured":"Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9(8):454\u201367. https:\/\/doi.org\/10.1038\/nrgastro.2012.115.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"6297_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/MCB.20.3.1089-1094.2000","volume":"20","author":"J Niedermeyer","year":"2000","unstructured":"Niedermeyer J, Kriz M, Hilberg F, Garin-Chesa P, Bamberger U, et al. Targeted disruption of mouse fibroblast activation protein. Mol Cell Biol. 2000;20(3):1089\u201394. https:\/\/doi.org\/10.1128\/MCB.20.3.1089-1094.2000.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"6297_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ccell.2021.02.017","volume":"39","author":"CD Madsen","year":"2021","unstructured":"Madsen CD. Pancreatic cancer is suppressed by fibroblast-derived collagen I. Cancer Cell. 2021;39(4):451\u20133. https:\/\/doi.org\/10.1016\/j.ccell.2021.02.017.","journal-title":"Cancer Cell"},{"issue":"6","key":"6297_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2967\/jnumed.120.253062","volume":"62","author":"M R\u00f6hrich","year":"2021","unstructured":"R\u00f6hrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, et al. Impact of (68)Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas. J Nucl Med. 2021;62(6):779\u201386. https:\/\/doi.org\/10.2967\/jnumed.120.253062.","journal-title":"J Nucl Med"},{"issue":"8","key":"6297_CR9","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00259-022-05729-5","volume":"49","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Jia G, Pan G, Cao K, Yang Q, et al. Comparison of the diagnostic efficacy of (68) Ga-FAPI-04 PET\/MR and (18)F-FDG PET\/CT in patients with pancreatic cancer. Eur J Nucl Med Mol Imag. 2022;49(8):2877\u201388. https:\/\/doi.org\/10.1007\/s00259-022-05729-5.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"4","key":"6297_CR10","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s00259-021-05576-w","volume":"49","author":"Y Pang","year":"2022","unstructured":"Pang Y, Zhao L, Shang Q, Meng T, Zhao L, et al. Positron emission tomography and computed tomography with [(68)Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. Eur J Nucl Med Mol Imag. 2022;49(4):1322\u201337. https:\/\/doi.org\/10.1007\/s00259-021-05576-w.","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"7","key":"6297_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/RLU.0000000000003561","volume":"46","author":"M Deng","year":"2021","unstructured":"Deng M, Chen Y, Cai L. Comparison of 68Ga-FAPI and 18[F]F-FDG PET\/CT in the imaging of pancreatic cancer with liver metastases. Clin Nucl Med. 2021;46(7):589\u201391. https:\/\/doi.org\/10.1097\/RLU.0000000000003561.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"6297_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijsu.2013.02.023","volume":"11","author":"B Nakata","year":"2013","unstructured":"Nakata B, Amano R, Kimura K, Hirakawa K. Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis. Int J Surg. 2013;11(4):344\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2013.02.023.","journal-title":"Int J Surg"},{"key":"6297_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06100-4","author":"J Ding","year":"2023","unstructured":"Ding J, Qiu J, Hao Z, Huang H, Liu Q, et al. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET\/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics. Eur J Nucl Med Mol Imaging. 2023. https:\/\/doi.org\/10.1007\/s00259-022-06100-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5.5","key":"6297_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.6004\/jnccn.2019.5007","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA. NCCN Guidelines Updates: Pancreatic Cancer. J Natl Compr Canc Netw. 2019;17(5.5):603\u20135. https:\/\/doi.org\/10.6004\/jnccn.2019.5007.","journal-title":"J Natl Compr Canc Netw."},{"issue":"2","key":"6297_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Histopathology"},{"issue":"4","key":"6297_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF02988521","volume":"17","author":"T Higashi","year":"2003","unstructured":"Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) \u2013usefulness and limitations in \u201cclinical reality.\u201d Ann Nucl Med. 2003;17(4):261\u201379. https:\/\/doi.org\/10.1007\/BF02988521.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"6297_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00259-021-05554-2","volume":"49","author":"Y Liu","year":"2022","unstructured":"Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, et al. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. Eur J Nucl Med Mol Imaging. 2022;49(3):871\u201380. https:\/\/doi.org\/10.1007\/s00259-021-05554-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6297_CR18","doi-asserted-by":"publisher","first-page":"660215","DOI":"10.3389\/fonc.2021.660215","volume":"11","author":"J Xing","year":"2021","unstructured":"Xing J, Yang B, Hou X, Jia N, Gong X, et al. Prognostic factors and effect of adjuvant chemoradiation following chemotherapy in resected pancreatic cancer patients with lymph node metastasis or R1 resection. Front Oncol. 2021;11:660215. https:\/\/doi.org\/10.3389\/fonc.2021.660215.","journal-title":"Front Oncol."},{"issue":"2","key":"6297_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPA.0b013e31816618ce","volume":"37","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Alpaugh RK, Palazzo I, Meropol NJ, Rogatko A, Xu Z, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas. 2008;37(2):154\u20138. https:\/\/doi.org\/10.1097\/MPA.0b013e31816618ce.","journal-title":"Pancreas"},{"issue":"8","key":"6297_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3748\/wjg.v18.i8.840","volume":"18","author":"M Shi","year":"2012","unstructured":"Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, et al. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol. 2012;18(8):840\u20136. https:\/\/doi.org\/10.3748\/wjg.v18.i8.840.","journal-title":"World J Gastroenterol"},{"key":"6297_CR21","doi-asserted-by":"publisher","unstructured":"21.Menezes S, Okail MH, Jalil SMA, Kocher HM, Cameron AJM. Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets. 2022;257(4):526-544. https:\/\/doi.org\/10.1002\/path.5926.","DOI":"10.1002\/path.5926"},{"issue":"9","key":"6297_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6297_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28. https:\/\/doi.org\/10.1186\/s12943-021-01316-8.","journal-title":"Mol Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06297-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06297-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06297-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T23:24:40Z","timestamp":1698449080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06297-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6297"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06297-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the Institutional Ethics Committee of the Peking Union Medical College Hospital (Beijing, China, IRB protocol #ZS1810).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}